公司簡介

宏聲醫療科技(香港)有限公司

Currently worldwide, intravitreal injection is the most common treatment for a wide range of retinal diseases. It is a horrifying, painful process that could induce a series of side effects. For most patients, they have to endure monthly, or even weekly injections to effectively treat their disease. Developed by Sonikure Technology aiming to replace needle injections, the Sonikure device safely and efficiently deliver drugs into the eye via our patented low energy and low intensity ultrasonic technology. Compatible to commercial viable eye drugs, the treatment is non-invasive, painless, and proven complication-free in pre-clinical trials.

Unit 208C, 2/F, Enterprise Place No. 5 Science Park West Avenue Hong Kong Sicence Park, Pak Shek Kok,HK
+852 2520 0220
Ms. Sarah Cheung

以上資料僅供參考。有關園區公司的最新資訊,請以其官方公布的訊息為準。

聯絡我們

如有查詢或對香港科技園的服務與援助計劃有疑問,請在下方空白處填寫您的電郵地址和詢問內容。